International Consortia:

Demontis, D., Walters, R. K., Martin, J., Mattheisen, M., Als, T. D., Agerbo, E., Baldursson, G.,
Belliveau, R., Bybjerg-Grauholm, J., Bækvad-Hansen, M., Cerrato, F., Chambert, K., Churchhouse, C.,
Dumont, A., Eriksson, N., Gandal, M., Goldstein, J. I., Grasby, K. L., Grove, J., Gudmundsson,
O. O., … Neale, B. M. (2019). Discovery of the first genome-wide significant risk loci for attention
deficit/hyperactivity disorder.
Nature genetics, 51(1), 63–75.
https://doi.org/10.1038/s41588-018-0269-7

 

Martin, J., Walters, R. K., Demontis, D., Mattheisen, M., Lee, S. H., Robinson, E., Brikell, I., Ghirardi, L.,
Larsson, H., Lichtenstein, P., Eriksson, N., 23andMe Research Team, Psychiatric Genomics Consortium:
ADHD Subgroup, iPSYCH–Broad ADHD Workgroup, Werge, T., Mortensen, P. B., Pedersen, M. G.,
Mors, O., Nordentoft, M., Hougaard, D. M., … Neale, B. M. (2018). A Genetic Investigation of Sex Bias
in the Prevalence of Attention-Deficit/Hyperactivity Disorder.
Biological psychiatry, 83(12), 1044–1053.
https://doi.org/10.1016/j.biopsych.2017.11.026 (Impact Factor 2016: 11.412).
 

Maier, R., Moser, G., Chen, G. B., Ripke, S., Cross-Disorder Working Group of the Psychiatric Genomics Consortium,
Coryell, W., Potash, J. B., Scheftner, W. A., Shi, J., Weissman, M. M., Hultman, C. M., Landén, M., Levinson, D. F.,
Kendler, K. S., Smoller, J. W., Wray, N. R., & Lee, S. H. (2015). Joint analysis of psychiatric disorders increases
accuracy of risk prediction for schizophrenia, bipolar disorder, and major depressive disorder.
American journal
of human genetics
, 96(2), 283–294. https://doi.org/10.1016/j.ajhg.2014.12.006 (Impact Factor 2014: 10.987).
 

Network and Pathway Analysis Subgroup of Psychiatric Genomics Consortium (2015). Psychiatric genome-wide association
study analyses implicate neuronal, immune and histone pathways.
Nature neuroscience, 18(2), 199–209.
https://doi.org/10.1038/nn.3922 (Impact Factor 2013: 14.976).
 

Jarick, I., Volckmar, A. L., Pütter, C., Pechlivanis, S., Nguyen, T. T., Dauvermann, M. R., Beck, S., Albayrak, Ö., Scherag, S.,
Gilsbach, S., Cichon, S., Hoffmann, P., Degenhardt, F., Nöthen, M. M., Schreiber, S., Wichmann, H. E., Jöckel, K. H., Heinrich, J.,
Tiesler, C. M., Faraone, S. V., … Hinney, A. (2014). Genome-wide analysis of rare copy number variations reveals PARK2 as
a candidate gene for attention-deficit/hyperactivity disorder.
Molecular psychiatry, 19(1), 115–121.
https://doi.org/10.1038/mp.2012.161 (Impact Factor 2013: 15,147).
 

Steinberg, S., de Jong, S., Mattheisen, M., Costas, J., Demontis, D., Jamain, S., Pietiläinen, O. P., Lin, K., Papiol, S.,
Huttenlocher, J., Sigurdsson, E., Vassos, E., Giegling, I., Breuer, R., Fraser, G., Walker, N., Melle, I., Djurovic, S., Agartz, I.,
Tuulio-Henriksson, A., … Stefansson, K. (2014). Common variant at 16p11.2 conferring risk of psychosis.
Molecular psychiatry, 19(1), 108–114. https://doi.org/10.1038/mp.2012.157 (Impact Factor 2013: 15.147).
 

Cross-Disorder Group of the Psychiatric Genomics Consortium, Lee, S. H., Ripke, S., Neale, B. M., Faraone, S. V., Purcell, S. M.,
Perlis, R. H., Mowry, B. J., Thapar, A., Goddard, M. E., Witte, J. S., Absher, D., Agartz, I., Akil, H., Amin, F., Andreassen, O. A.,
Anjorin, A., Anney, R., Anttila, V., Arking, D. E., … International Inflammatory Bowel Disease Genetics Consortium (IIBDGC)
(2013).Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs.
Nature genetics, 45(9), 984–994. https://doi.org/10.1038/ng.2711 (Impact Factor 2012: 35.209).


Yang, L., Neale, B. M., Liu, L., Lee, S. H., Wray, N. R., Ji, N., Li, H., Qian, Q., Wang, D., Li, J., Faraone, S. V., Wang, Y.,
& Psychiatric GWAS Consortium: ADHD Subgroup (2013). Polygenic transmission and complex neuro developmental
network for attention deficit hyperactivity disorder: genome-wide association study of both common and rare variants
.
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of
Psychiatric Genetics
, 162B(5), 419–430. https://doi.org/10.1002/ajmg.b.32169 (Impact Factor 2012: 3.231).
 

Hamshere, M. L., Langley, K., Martin, J., Agha, S. S., Stergiakouli, E., Anney, R. J., Buitelaar, J., Faraone, S. V., Lesch, K. P.,
Neale, B. M., Franke, B., Sonuga-Barke, E., Asherson, P., Merwood, A., Kuntsi, J., Medland, S. E., Ripke, S., Steinhausen, H. C.,
Freitag, C., Reif, A., … Thapar, A. (2013). High loading of polygenic risk for ADHD in children with comorbid aggression.
The American journal of psychiatry, 170(8), 909–916. https://doi.org/10.1176/appi.ajp.2013.12081129 (Impact Factor 2012: 14.721).
 

Williams, N. M., Franke, B., Mick, E., Anney, R. J., Freitag, C. M., Gill, M., Thapar, A., O'Donovan, M. C., Owen, M. J., Holmans, P.,
Kent, L., Middleton, F., Zhang-James, Y., Liu, L., Meyer, J., Nguyen, T. T., Romanos, J., Romanos, M., Seitz, C., Renner, T. J., …
Faraone, S. V. (2012). Genome-wide analysis of copy number variants in attention deficit hyperactivity disorder: the role of
rare variants and duplications at 15q13.3
. The American journal of psychiatry, 169(2), 195–204.
https://doi.org/10.1176/appi.ajp.2011.11060822  (Impact Factor 2010: 12.759).
 

Stergiakouli, E., Hamshere, M., Holmans, P., Langley, K., Zaharieva, I., deCODE Genetics, Psychiatric GWAS Consortium,
Hawi, Z., Kent, L., Gill, M., Williams, N., Owen, M. J., O'Donovan, M., & Thapar, A. (2012). Investigating the contribution of
common genetic variants to the risk and pathogenesis of ADH
D. The American journal of psychiatry, 169(2), 186–194.
https://doi.org/10.1176/appi.ajp.2011.11040551 (Impact Factor 2010: 12.759).
 

Elia, J., Glessner, J. T., Wang, K., Takahashi, N., Shtir, C. J., Hadley, D., Sleiman, P. M., Zhang, H., Kim, C. E., Robison, R., Lyon,
G. J., Flory, J. H., Bradfield, J. P., Imielinski, M., Hou, C., Frackelton, E. C., Chiavacci, R. M., Sakurai, T., Rabin, C.,
Middleton, F. A., …Hakonarson, H. (2011). Genome-wide copy number variation study associates metabotropic glutamate
receptor gene networkswith attention deficit hyperactivity disorder
. Nature genetics, 44(1), 78–84.
https://doi.org/10.1038/ng.1013 (Impact Factor 2010: 36.377).
 

Jain, M., Vélez, J. I., Acosta, M. T., Palacio, L. G., Balog, J., Roessler, E., Pineda, D., Londoño, A. C., Palacio, J. D., Arbelaez, A.,
Lopera, F., Elia, J., Hakonarson, H., Seitz, C., Freitag, C. M., Palmason, H., Meyer, J., Romanos, M., Walitza, S.,
Hemminger, U., … Muenke, M. (2012). A cooperative interaction between LPHN3 and 11q doubles the risk for ADHD.
Molecular psychiatry, 17(7), 741–747. https://doi.org/10.1038/mp.2011.59 (Impact Factor 2010: 15.049).

 

Published / in press:
 

2020

95. Schote, A. B., Schiel, F., Schmitt, B., Winnikes, U., Frank, N., Gross, K., Croyé, M. A., Tarragon, E.,
Bekhit, A., Bobbili, D. R., May, P., Schick, C., & Meyer, J. (2020). Genome-wide linkage analysis of families
with primary hyperhidrosis. PloS one, 15(12), e0244565.
https://doi.org/10.1371/journal.pone.0244565

 

94. Tarragon, E., Bindila, L., Zimmer, P., Lutz, B., & Meyer, J. (2020). Salivary endocannabinoids as mediators
in the relationship between omega-6 and omega-3 fatty acid ratio intake from highly-processed foods and
anthropometric markers of health in women. International journal of food sciences and nutrition, 71(2), 235–241.
https://doi.org/10.1080/09637486.2019.1632274
 

2019

93. Waltes, R., Freitag, C. M., Herlt, T., Lempp, T., Seitz, C., Palmason, H., Meyer, J., & Chiocchetti, A. G. (2019).
Impact of autism-associated genetic variants in interaction with environmental factors on ADHD comorbidities:
an exploratory pilot study. Journal of neural transmission (Vienna, Austria : 1996), 126(12), 1679–1693.
https://doi.org/10.1007/s00702-019-02101-0
 

92. Yurtsever, T., Streit, F., Foo, J. C., Trifonova, S., Kumsta, R., Muller, C. P., Turner, J. D., Meyer, J., & Schote, A. B. (2019).
Temporal dynamics of cortisol-associated changes in mRNA expression of glucocorticoid responsive genes FKBP5,
GILZ, SDPR, PER1, PER2 and PER3 in healthy humans. Psychoneuroendocrinology, 102, 63–67.
https://doi.org/10.1016/j.psyneuen.2018.11.033
 

91. Li-Tempel, T., Suer, T., Tempel, T., Larra, M. F., Winnikes, U., Schächinger, H., Meyer, J., & Schote, A. B. (2019).
Promoter haplotypes of the corticotropin-releasing hormone encoding gene modulate the physiological stress response
in vitro and in vivo. Stress (Amsterdam, Netherlands), 22(1), 44–52. https://doi.org/10.1080/10253890.2018.1501020
 

90. Schote, A. B., A L Sayk, C., Pabst, K., Meier, J. K., Frings, C., & Meyer, J. (2019). Sex, ADHD symptoms, and CHRNA5
genotype influence reaction time but not response inhibition. Journal of neuroscience research, 97(2), 215–224.
https://doi.org/10.1002/jnr.24342
 

89. Schote, A. B., Jäger, K., Kroll, S. L., Vonmoos, M., Hulka, L. M., Preller, K. H., Meyer, J., Grünblatt, E., & Quednow, B. B.
(2019). Glucocorticoid receptor gene variants and lower expression of NR3C1 are associated with cocaine use.
Addiction biology, 24(4), 730–742. https://doi.org/10.1111/adb.12632
 

2018

88. Freilinger, P., Kliegel, D., Hänig, S., Oehl-Jaschkowitz, B., Henn, W., & Meyer, J. (2018). Behavioral and psychological
features in girls and women with triple-X syndrome. American journal of medical genetics. Part A, 176(11), 2284–2291.
https://doi.org/10.1002/ajmg.a.40477


Tarragon, E., Stein, J., & Meyer, J. (2018). Basal Levels of Salivary Alpha-Amylase Are Associated with Preference for Foods
High in Sugar and Anthropometric Markers of Cardiovascular Risk. Behavioral sciences (Basel, Switzerland), 8(10), 94.
https://doi.org/10.3390/bs8100094

 

2017

87. Tarragon, E., Stein, J., & Meyer, J. (2017). Psychometric Properties of the German Translated Version and Adaptation
of the Food Craving Inventory. Frontiers in psychology, 8, 736. https://doi.org/10.3389/fpsyg.2017.00736 (Impact Factor 2016: 2.321).
 

2016

86. Kranz, T. M., Kopp, M., Waltes, R., Sachse, M., Duketis, E., Jarczok, T. A., Degenhardt, F., Görgen, K., Meyer, J.,
Freitag, C. M., & Chiocchetti, A. G. (2016). Meta-analysis and association of two common polymorphisms of the
human oxytocin receptor gene in autism spectrum disorder. Autism research : official journal of the International Society
for Autism Research
, 9(10), 1036–1045. https://doi.org/10.1002/aur.1597 (Impact Factor 2014: 4.330).
 

85.  Mooney, M. A., McWeeney, S. K., Faraone, S. V., Hinney, A., Hebebrand, J., IMAGE2 Consortium, German ADHD
GWAS Group
,Nigg, J. T., & Wilmot, B. (2016). Pathway analysis in attention deficit hyperactivity disorder: An ensemble
approach. American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the
International Society of Psychiatric Genetics
,171(6), 815–826. https://doi.org/10.1002/ajmg.b.32446 (Impact Factor 2012: 3.231).
 

84. Schote, A. B., Bonenberger, M., Pálmason, H., Seitz, C., Meyer, J., & Freitag, C. M. (2016). Glucocorticoid receptor
variants in childhood attention-deficit/hyperactivity disorder and comorbid psychiatric disorders. Psychiatry research,
246, 275–283. https://doi.org/10.1016/j.psychres.2016.10.001 (Impact Factor 2015: 2.466).


83. Li-Tempel, T., Larra, M. F., Winnikes, U., Tempel, T., DeRijk, R. H., Schulz, A., Schächinger, H., Meyer, J.,
& Schote, A. B. (2016). Polymorphisms of genes related to the hypothalamic-pituitary-adrenal axis influence the cortisol awakening
response as well as self-perceived stress. Biological psychology, 119, 112–121. https://doi.org/10.1016/j.biopsycho.2016.07.010 (Impact Factor 2015: 3.234).
 

82. Yurtsever, T., Schilling, T. M., Kölsch, M., Turner, J. D., Meyer, J., Schächinger, H., & Schote, A. B. (2016). The acute
and temporary modulation of PERIOD genes by hydrocortisone in healthy subjects. Chronobiology international, 33(9), 1222–1234.
https://doi.org/10.1080/07420528.2016.1211668 (Impact Factor 2015: 3.343).
 

81. Zenglein, Y., Schwenck, C., Westerwald, E., Schmidt, C., Beuth, S., Meyer, J., Palmason, H., Seitz, C., Hänig, S., & Freitag,
C. M. (2016). Empirically Determined, Psychopathological Subtypes in Children With ADHD. Journal of attention disorders,
20(2), 96–107. https://doi.org/10.1177/1087054713508312 (Impact Factor 2012: 2.163).
 

80. Breitenstein, B., Scheuer, S., Brückl, T. M., Meyer, J., Ising, M., Uhr, M., & Holsboer, F. (2016). Association of ABCB1 gene
variants, plasma antidepressant concentration, and treatment response: Results from a randomized clinical study. Journal of
psychiatric research
, 73, 86–95. https://doi.org/10.1016/j.jpsychires.2015.11.010 (Impact Factor 2014: 3.957).
 

79. Schneider, K. K., Frings, C., Meyer, J., & Schote, A. B. (2016). The role of the glucocorticoid receptor gene (NR3C1)
for the processing of aversive stimuli. Neuroscience research, 107, 8–13. https://doi.org/10.1016/j.neures.2015.11.008 (Impact Factor 2014: 1.997).

 

2015

78. Schneider, K. K., Hüle, L., Schote, A. B., Meyer, J., & Frings, C. (2015). Sex matters! Interactions of sex and polymorphisms
of a cholinergic receptor gene (CHRNA5) modulate response speed. Neuroreport, 26(4), 186–191.
https://doi.org/10.1097/WNR.0000000000000313  (Impact Factor 2013: 1,644).


77. Schneider, K. K., Schote, A. B., Meyer, J., & Frings, C. (2015). Genes of the dopaminergic system selectively modulate
top-down but not bottom-up attention. Cognitive, affective & behavioral neuroscience, 15(1), 104–116. https://doi.org/10.3758/s13415-014-0320-9  (Impact Factor 2013: 3.209).


76. Schneider, K. K., Schote, A. B., Meyer, J., Markett, S., Reuter, M., & Frings, C. (2015). Individual response speed is
modulated by variants of the gene encoding the alpha 4 sub-unit of the nicotinic acetylcholine receptor (CHRNA4).
Behavioural brain research, 284

, 11–18. doi.org/10.1016/j.bbr.2015.01.041   (Impact Factor 2013: 3,391).


 

75. Chiocchetti, A. G., Kopp, M., Waltes, R., Haslinger, D., Duketis, E., Jarczok, T. A., Poustka, F., Voran, A., Graab, U.,
Meyer, J., Klauck, S. M., Fulda, S., & Freitag, C. M. (2015). Variants of the CNTNAP2 5' promoter as risk factors for autism
spectrum disorders: a genetic and functional approach. Molecular psychiatry, 20(7), 839–849. https://doi.org/10.1038/mp.2014.103 (Impact Factor 2013: 15.147).

 

2014

74. Gross, K. M., Schote, A. B., Schneider, K. K., Schulz, A., & Meyer, J. (2014). Elevated social stress levels and
depressive symptoms in primary hyperhidrosis. PloS one, 9(3), e92412. https://doi.org/10.1371/journal.pone.0092412 (Impact Factor 2012: 3.730).
 

73. Waltes, R., Duketis, E., Knapp, M., Anney, R. J., Huguet, G., Schlitt, S., Jarczok, T. A., Sachse, M., Kämpfer, L. M.,
Kleinböck, T., Poustka, F., Bölte, S., Schmötzer, G., Voran, A., Huy, E., Meyer, J., Bourgeron, T., Klauck, S. M.,
Freitag, C. M., & Chiocchetti, A. G. (2014). Common variants in genes of the postsynaptic FMRP signalling pathway are
risk factors for autism spectrum disorders. Human genetics, 133(6), 781–792. https://doi.org/10.1007/s00439-013-1416-y (Impact Factor 2012: 4.633).

 

2013        

72. Lin, M. K., Freitag, C. M., Schote, A. B., Pálmason, H., Seitz, C., Renner, T. J., Romanos, M., Walitza, S., Jacob, C. P.,
Reif, A., Warnke, A., Cantor, R. M., Lesch, K. P., & Meyer, J. (2013). Haplotype co-segregation with attention deficit-
hyperactivity disorder in unrelated German multi-generation families. American journal of medical genetics. Part B,
Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics
, 162B(8), 855–863.
https://doi.org/10.1002/ajmg.b.32192 (Impact Factor 2012: 3.231).
 

71. Habel, J.C., Cox, S., Gassert, F., Mulwa R.K., Meyer J. & Lens L. (2013). Population genetics of the East African
White-eye species complex. Conserv Genet14, 1019–1028. https://doi.org/10.1007/s10592-013-0492-9 (Impact Factor 2011: 1.610).
 

70.  Mertins, V., Schote, A. B., & Meyer, J. (2013). Variants of the Monoamine Oxidase A gene (MAOA) predict
free-riding behavior in women in a strategic public goods experiment. Journal of Neuroscience, Psychology,
and Economics, 6
(2), 97–114. https://doi.org/10.1037/a0032877 (Impact Factor 2011: 1.760).

69. Gassert F, Schulte U, Husemann M, Ulrich W, Rödder D, Hochkirch A, Engel E, Meyer J, Habel JC (2013):
From southern refugia to the northern range margin: genetic population structure of the common wall lizard, Podarcis muralis;
J. Biogeogr. (in press). (Impact Factor 2011: 4.544).
 

68. Trost S, Platz B, Usher J, Scherk H, Wobrock T, Ekawardhani S, Meyer J, Reith W, Falkai P, Gruber O (2013):
DISC1 (disrupted in schizophrenia 1) is associated with cortical grey matter volumes in the human brain:
A voxel-based morphometry (VBM) study;
J. Psychiatr. Res. 47: 188-196. (Impact Factor 2011: 4.464).
 

67. Trost S, Platz B, Usher J, Scherk H, Wobrock T, Ekawardhani S, Meyer J, Reith W, Falkai P, Gruber O (2013):
The DTNBP1 (Dysbindin-1) gene variant rs2619522 is associated with variation of hippocampal and prefrontal
grey matter volumes in humans;
Eur. Arch. Psychiatr. Clin. Neurosci. 263: 53-63. (Impact Factor 2010: 3.637).

 

2012

66. Kranz T, Ekawardhani S, Lin MK, Alt SR, Streit F, Schuelter U, Bauer H, Henseler D, Turner JD, Muller CP,
Reif A, Schote AB, Meyer J (2012):
The chromosome 15q14 locus for bipolar disorder and schizophrenia: Is C15orf53 a major candidate gene?
J. Psychiatr. Res. 46: 1414-1420. (Impact Factor 2011: 4.464).
 

65. Zilles D, Meyer J, Schneider-Axmann T, Ekawardhani S, Gruber E, Falkai P, Gruber O (2012):
Genetic polymorphisms of 5-HTT and DAT but not COMT differentially affect verbal and visospatial working
memory functioning;
Eur. Arch. Psychiatry Clin. Neurosci. 262: 667-676. (Impact Factor 2010: 3.687).
 

64. Ribasés M, Ramos-Quiroga JA, Hervás A, Sánchez-Mora C, Bosch R, Bielsa A, Gastaminza X, Lesch KP,
Reif A, Renner TJ, Romanos M, Warnke A, Walitza S, Freitag C, Seitz C, Meyer J, Pálmason H, Casas M,
Bayés M, Cormand B (2012):
Candidate system analysis in ADHD: Evaluation of 9 genes involved in dopaminergic neurotransmission
identifies association with DRD1;
World J. Biol. Psychiatry 13: 281 - 292. (Impact Factor 2010: 5.564).
 

63. Freitag CM, Hänig S, Schneider A, Seitz C, Pálmason H, Retz W, Meyer J (2012):
Biological and psychosocial environmental risk factors influence symptom severity and psychiatric
comorbidity in children with ADHD
;
J. Neural Transm. 119: 81-94. (Impact Factor 2010: 2.597).

 

2011

62. Henseler D, Turner JD, Eckhardt M, van der Mark M, Revsin J, Lin MK, Kranz T, Muller C, Meyer J (2011):
Unusual 5’-regulatory structure and regulation of the murine Mlc1 gene: Lack of promoter-specific elements;
JNAI [Epub ahead of print].
 

61. Kröger A, Hänig S, Seitz C, Pálmason H, Meyer J, Freitag CM (2011):
Risk factors of autistic symptoms in children with ADHD;
Eur. Child. Adolesc. Psychiatry 20: 561-570. (Impact Factor 2010: 1.622).

60. Hinney A, Scherag A, Jarick I, Albayrak Ö, Pütter C, Pechlivanis S, Dauvermann MR, Beck S, Weber
H, Scherag, S, Nguyen TT, Volckmar A-L, Knoll N, Faraone SV, Neale BM, Franke B, Psychiatric GWAS Consortium:
ADHD subgroup, Cichon S, Hoffmann P, Nöthen MM, Schreiber S, Jöckel K-H, Wichmann H-E, Freitag C,
Lempp T, Meyer J, Gilsbach S, Herpertz-Dahlmann B, Sinzig J, Lehmkuhl G, Renner TJ, Warnke A, Romanos M,
Lesch K-P, Reif A, Schimmelmann BG, Hebebrand J (2011):
Genome-wide association study in German patients with attention deficit / hyperactivity disorder;
Am. J. Med. Genet. Neuropsychiatr. Genet. 156B: 888-897. (Impact Factor 2010: 4.156).
 

59. Reif A, Nguyen TT, Weißflog L, Jacob CP, Romanos M, Renner TJ, Buttenschon HN, Kittel-Schneider S,
Gessner A, Weber H, Neuner M, Gross-Lesch S, Zamzow K, Kreiker S, Walitza S, Meyer J, Freitag CM, Bosch R,
Casas M, Gómez N, Ribasès M, Bayès M, Buitelaar JK, Kiemeney LALM, Kooij JJS, Kan CC, Hoogman M,
Johansson S, Jacobsen KK, Knappskog PM, Fasmer OB, Asherson P, Warnke A, Grabe HJ, Mahler J, Teumer A,
Völzke H, Mors ON, Schäfer H, Ramos-Quiroga JA, Cormand B, Haavik J, Franke B, Lesch KP (2011):
DIRAS2 is associated with adult ADHD, related traits, and co-morbid disorders;
Neuropsychopharmacology 36: 2318 - 2327. (Impact Factor 2010: 6.685).
 

58. Mertins V, Schote AB, Hoffeld W, Griessmair M, Meyer J (2011):
Genetic Susceptibility for Individual Cooperation Preferences: The Role of Monoamine Oxidase A Gene (MAOA)
in the VoluntaryProvision of Public Goods;
PLoS ONE 6(6): e20959. [Epub 2011 Jun 16]. (Impact Factor 2010: 4.411).
 

57. Gruber O, Hasan A, Scherk H, Wobrock T, Schneider-Axmann T, Ekawardhani S, Schmitt A, Backens M, Reith W,
Meyer J, Falkai P (2011):
Association of the brain-derived neurotrophic factor (BDNF) val66met polymorphism with magnetic resonance spectroscopic
markers in the human hippocampus: in vivo evidence for effects on the glutamate system;
Eur. Arch. Psychiatr. Clin. Neurosci. [Epub ahead of print]. (Impact Factor 2009: 2.247).
 

56. Cao L, Leija SC, Kumsta R, Wüst S, Meyer J, Turner JD, Muller CP (2011):
Transcriptional control of the human glucocorticoid receptor: identification and analysis of alternative promoter regions;
Hum Genet. 129: 533-543. (Impact Factor 2009: 4.523)

 

2010

55. Neale BM, Medland S, Ripke S, Anney RJ, Asherson P, Buitelaar J, Franke B, Gill M, Kent L, Holmans P, Middleton F,
Thapar A, Lesch KP, Faraone SV, Daly M, Nguyen TT, Schäfer H, Steinhausen HC, Reif A, Renner TJ, Romanos M,
Romanos J, Warnke A, Walitza S, Freitag C, Meyer J, Pálmason H, Rothenberger A, Hawi Z, Sergeant J, Roeyers H,
Mick E, Biederman J; IMAGE II Consortium (2010):
Case-control genome-wide association study of attention-deficit/hyperactivity disorder
J. Am. Acad. Child Adolesc. Psychiatry 49: 906-920. (Impact Factor 2009: 4.854).
 

54. Neale BM, Medland SE, Ripke S, Asherson P, Franke B, Lesch KP, Faraone SV, Nguyen TT, Schäfer H, Holmans P,
Daly M, Steinhausen HC, Freitag C, Reif A, Renner TJ, Romanos M, Romanos J, Walitza S, Warnke A, Meyer J,
Pálmason H, Buitelaar J, Vasquez AA, Lambregts-Rommelse N, Gill M, Anney RJ, Langely K, O'Donovan M, Williams N,
Owen M, Thapar A, Kent L, Sergeant J, Roeyers H, Mick E, Biederman J, Doyle A, Smalley S, Loo S, Hakonarson H,
Elia J, Todorov A, Miranda A, Mulas F, Ebstein RP, Rothenberger A, Banaschewski T, Oades RD, Sonuga-Barke E,
McGough J, Nisenbaum L, Middleton F, Hu X, Nelson S; Psychiatric GWAS Consortium: ADHD Subgroup (2010):
Meta-analysis of genome-wide association studies of attention deficit/hyperactivity disorder;
J. Am. Acad. Child Adolesc. Psychiatry 49: 884-897. (Impact Factor 2009: 4.854).
 

53. M. Arcos-Burgos, M. Jain, M. T. Acosta, S. Shively, H. Stanescu, D. Wallis, S. Domené, J. I. Vélez, J. D. Karkera,
J. Balog, K. Berg, R. Kleta, W. A. Gahl, E. Roessler, R. Long, J. Lie, D. Pineda, A. C. Londoño, J. D. Palacio, A. Arbelaez,
F. Lopera, J. Elia, H. Hakonarson, S. Johansson, P. M. Knappskog, J. Haavik, M. Ribases, B. Cormand, M. Bayes,
M. Casas, T. Ramos, A. Hervas, B. S. Maher, C. Seitz, C. M. Freitag, H. Pálmason, J. Meyer, M. Romanos, S. Walitza,
U. Hemminger, Andreas Warnke, J. Romanos, T. Renner, C. Jacob, K.-P. Lesch, S. V. Faraone, J. Swanson, A. Vortmeyer,
J. E. Bailey-Wilson, F. X. Castellanos, M. Muenke (2010):
A common variant of latrophilin 3 (LPHN3) confers susceptibility to ADHD and predicts effectiveness of stimulant medication;
Mol. Psychiatry 15: 1053-1066. (Impact Factor 2008: 12.537).
 

52. H. Pálmason, D. Moser, J. Sigmund, C. Vogler, S. Hänig, A. Schneider, C. Seitz, A. Marcus, J. Meyer, C. Freitag (2010):
Attention deficit / hyperactivity disorder phenotype is influenced by a functional catechol-O-methyltransferase (COMT) variant;
J. Neural Transm. 117: 259-267. (Impact Factor 2008: 2.514).
 

51. C. M. Freitag, K. Agelopoulos, E. Huy, M. Rothermundt, P. Krakowitzky, J. Meyer, J. Deckert, A. von Gontard, C. Hohoff (2010):
Adenosine A2A receptor gene (ADORA2A) variants may increase autistic symptoms and anxiety in autism spectrum disorder;
Eur. Child Adolesc. Psychiatry 19: 67-74. (Impact Factor 2008: 1.769).

 

2009

50. H. Scherk, M. Backens, T. Schneider-Axmann, S. Kraft, C. Kemmer, J. Usher, W. Reith, P. Falkai, J. Meyer, O. Gruber (2009):
Dopamine Transporter genotype influences N-acetyl-aspartate in left putamen;
World J. Biol. Psychiatr. 10: 524 – 530. (Impact Factor 2008: 3.582).
 

49. B. G. Schimmelmann, S. Friedel, T. T. Nguyen, S. Sauer, C. I., Vogel, K. Konrad, C. Wilhelm, J. Sinzig, T. J. Renner, M. Romanos,
H. Pálmason, A. Dempfle, S. Walitza, C. Freitag, J. Meyer, M. Linder, H. Schäfer, A. Warnke, K. P. Lesch, B. Herpertz-Dahlman,
A. Hinney, J. Hebebrand (2009):
Exploring the genetic link between RLS and ADHD;
J. Psychiatr. Res. 43: 941-945. (Impact Factor 2007: 3.710).
 

48. C. M. Freitag, S. Hänig, H. Pálmason, J. Meyer, S. Wüst, C. Seitz (2009):
Cortisol awakening response in healthy children and children with ADHD:
Impact of comorbid disorders and psychosocial risk factors;
Psychoneuroendocrinology 34: 1019-1028. (Impact Factor 2007: 4.422).
 

47. R. Kumsta, D. Moser, F. Streit, J. W. Koper, J. Meyer, S. Wüst (2009):
Characterization of a glucocorticoid receptor gene (GR, NR3C1) promoter polymorphism reveals functionality
and extends a haplotype with putative clinical relevance;
Am. J. Med. Genet. B Neuropsychiatr. Genet. 150B: 476-482. (Impact Factor 2007: 4.224).
 

46. D. Moser, S. Ekawardhani, R. Kumsta, H. Pálmason, C. Bock, Z. Athanassiadou, K. P. Lesch, J. Meyer (2009):
Functional analysis of a potassium-chloride co-transporter 3 (SLC12A6) promoter polymorphism leading to an
additional methylation site;
Neuropsychopharmacology 34: 458-467. (Impact Factor 2007: 6.157).
 

45. H. Scherk, O. Gruber, P. Menzel, T. Schneider-Axmann, C. Kemmer, J. Usher, W. Reith, J. Meyer, P. Falkai (2009):
5-HTTLPR genotype influences amygdala volume.
Eur. Arch. Psychiatry Clin. Neurosci. 259: 212-217. (Impact Factor 2007: 2.809).

 

2008

44. K. Zhou, Dempfle A, Arcos-Burgos M, Bakker SC, Banaschewski T, Biederman J, Buitelaar J, Castellanos FX,
Doyle A, Ebstein RP, Ekholm J, Forabosco P, Franke B, Freitag C, Friedel S, Gill M, Hebebrand J, Hinney A, Jacob C,
Lesch KP, Loo SK, Lopera F, McCracken JT, McGough JJ, Meyer J, Mick E, Miranda A, Muenke M, Mulas F,
Nelson SF, Nguyen TT, Oades RD, Ogdie MN, Palacio JD, Pineda D, Reif A, Renner TJ, Roeyers H, Romanos M,
Rothenberger A, Schäfer H, Sergeant J, Sinke RJ, Smalley SL, Sonuga-Barke E, Steinhausen HC, van der Meulen E,
Walitza S, Warnke A, Lewis CM, Faraone SV, Asherson P (2008):
Meta-analysis of genome-wide linkage scans of attention deficit hyperactivity disorder;
Am. J. Med. Genet. B Neuropsychiatr. Genet. 147B: 1392-1398 (Impact Factor 2007: 4.224).
 

43. K.-P. Lesch, Timmesfeld N, Renner TJ, Halperin R, Röser C, Nguyen TT, Craig DW, Romanos J, Heine M, Meyer J,
Freitag C, Warnke A, Romanos M, Schäfer H, Walitza S, Reif A, Stephan DA, Jacob C (2008):
Molecular genetics of adult ADHD: converging evidence from genome-wide association and extended pedigree linkage studies;
J. Neural Transm. 115: 1573-1585 (Impact Factor 2007: 2.672).
 

42. J. A. Macedo, J. Hesse, J. D. Turner, J. Meyer, D. H. Hellhammer, C. P. Muller (2008):
Glucocorticoid sensitivity in fibromyalgia patients: decreased expression of corticosteroid receptors and
glucocorticoid-induced leucine zipper;
Psychoneuroendocrinology 33: 799-809 (Impact Factor 2007: 4.850).
 

41. M. Romanos, C. Freitag, C. Jacob, D. W. Craig, T. T. Nguyen, R. Halperin, S. Walitza, T. J. Renner,
C. Seitz, J. Romanos, H. Pálmason, M. Heine, A. Dempfle, C. Windemuth-Kieselbach, C. Vogler, J. Sigmund,
A. Warnke1, H. Schäfer, J. Meyer, D. A. Stephan, K. P. Lesch (2008):
Genome-Wide Linkage Analysis of ADHD Using High Density SNP Genotyping Arrays:
Linkage to 5q13.1, 14q12 and 15q13.1;
Mol Psychiatry. 13: 522-530 (Impact Factor 2007: 10.900).

 

2006 – 2007

40.C. M. Freitag, P. Retz-Junginger , W. Retz, C. Seitz, H. Pálmason, J. Meyer, M. Rösler, A. von Gontard (2007):
Evaluation der deutschen Version des Autismus-Spektrum-Quotienten (AQ) - die Kurzversion AQk. Z. Klein.
Psychol. Psychother. 36: 280-289. (Impact Factor 2006: 0.660).
 

39. B. G. Schimmelmann, S. Friedel, B. Dempfle, A. Warnke, K. P. Lesch, S. Walitza, T. Renner, M. Romanos,
B. Herpertz-Dahlmann, M. Lindner, H. Schäfer, C. Seitz, H. Pálmason, C. Freitag, J. Meyer, K. Konrad, A. Hinney, J. Hebebrand (2007):
No evidence for preferential transmission of common valine66 allele of the Val66Met polymorphism of the brain-derived
neurotrophic factor gene (BDNF) in ADHD;
J. Neural Transm. 114: 523-526. (Impact Factor 2007: 2.672).
 

38. S. Selch, A. Strobel, J. Haderlein, J. Meyer, C. P. Jacob, A. Schmitt, K.-P. Lesch and A. Reif (2007):
MLC1 polymorphisms are specifically associated with periodic catatonia, a sub-group of chronic schizophrenia;
Biol. Psychiatry 61: 1211-1214. (Impact Factor 2005: 6.779).
 

37. S. Friedel, K. Saar, S. Sauer, A. Dempfle, S. Walitza, T. Renner, M. Romanos, C. Freitag, C. Seitz, H. Pálmason,
A. Scherag, C. Windemuth-Kieselbach, BG Schimmelmann, C. Wewetzer, J. Meyer, A. Warnke, KP. Lesch, Richard Reinhardt,
B. Herpertz-Dahlmann, M. Linder, A. Hinney, H. Remschmidt, J. Dupuis, H. Schäfer, K. Konrad, N. Hübner, J. Hebebrand (2007):
Association and linkage of allelic variants of the dopamine transporter gene in ADHD;
Mol. Psychiatry 12: 923-933 (Impact Factor 2007: 10.900).
 

36. C. Buss, U. Schuelter, J. Hesse, D. Moser, D. I. Phillips, D. Hellhammer, J. Meyer (2007):
Haploinsufficiency of the SERPINA6 gene is associated with severe muscle fatigue:
A de novo mutation in corticosteroid-binding globulin deficiency;
J. Neural Transm. 114: 563-569. (Impact Factor 2004: 2.628); OMIM #611489.
 

35. D. Moser, A, Molitor, R. Kumsta, P. Riederer, T. Tatschner, J. Meyer (2007):
The glucocorticoid receptor gene exon 1-F promoter is not methylated at the NGFI-A binding site in human hippocampus;
World J. Biol. Psychiatr. 8: 262-268. (Impact Factor 2006: 2.800).
 

34. J. R. Wendland, M. Hampe, T. K. Newman, Y. V. Syagailo, J. Meyer, W. Schempp,A. Timme, S. J. Suomi,
K. P. Lesch (2006):
Structural variation of the monoamine oxidase A gene promoter repeat polymorphism in nonhuman primates.
Genes Brain Behav. 5: 40-45. (Impact Factor 2005: 4.091).

 

2003 – 2005

 33. V. Steinke*, J. Meyer*, Y. V. Syagailo, G. Ortega, H. Hameister, R. Mössner, A. Schmitt, K. P. Lesch (2003):
Genomic organization of the murine Kiaa0027 (Wkl1, Mlc1) gene;
J. Neural Transm. 110: 333-343. (Impact Factor 2004: 2.628).*) please note: "both authors contributed equally to the work!"
 

32. A. Schmitt, V. Gofferje, M. Weber, J. Meyer, R. Mössner, K. P. Lesch (2003):
The brain-specific gene MLC1 implicated in megalencephalic leucoencephalopathy with subcortical cysts is expressed in
glial cells in the murine brain;
Glia 44: 283-295. (Impact Factor 2002: 4.193).
 

31. R. Mössner, R., A. Weichselbaum, M. Marziniak, C. M.Freitag, K. P. Lesch, C. Sommer,J. Meyer, (2005):
A highly polymorphic poly-glutamine stretch in the potassium channel KCNN3 in migraine with and without aura;
Headache 45: 132-136. (Impact Factor 2005: 2.455).
 

30. D. P. McKeane, J. Meyer, S. E. Dobrin, K. M. Melmed, N. A. Tracy, K. P. Lesch, D. A. Stephan (2005):
No causative DLL4 mutations in periodic catatonia patients from 15q15 linked families.
Schizophrenia Res. 75: 1-3. (Impact Factor 2005: 4.231).


29. Y. J. Lee, C. Hohoff, K. Domschke, P. Sand, G. Kuhlenbäumer, A. Schirmacher, C. M. Freitag, J. Meyer,
G. Stöber, P. Franke, M. M. Nöthen, J. Fritze, R. Fimmers, H. S. Garritsen, F. Stögbauer, J. Deckert (2005):
Norepinephrine transporter (NET) promoter and 5'-UTR polymorphisms: association analysis in panic disorder.
Neurosci. Lett. 377: 40-43. (Impact Factor 2005: 1.898).

28. J. Meyer, K. Johannssen, C. M. Freitag, K. Schraut, I. Teuber, A. Hahner, C. Mainhardt, R. Mössner, H.-P. Volz,
T. F. Wienker, D. McKeane, D. A. Stephan, G. Rouleau, A. Reif, K. P. Lesch (2005):
Rare variants of the gene encoding the potassium-chloride cotransporter 3 are associated with bipolar disorder;
Int. J. Neuropsychopharmacology 8: 495-594. (Impact Factor 2005: 3.918).
 

 27. S. Bellingrath, R. Kumsta, J. Meyer, D. Moser, I. S. Federenko, D. H. Hellhammer, S. Wüst (2005):
Assoziation eines Polymorphismus im H6PD Gen mit basaler Cortisolsekretion, Fettmasse und  Leptinwerten.
Z. Med. Psychol. 14: 111-117 [Article in German].

 

2000 – 2002

26. M. J. Arranz, J. Munro, J. Birkett, J. Bolonna, D. Macama, M. Sodhi, K. P. Lesch, J. F. W. Meyer, P. Sham,
D. A. Collier, R. M. Murray, R. W. Kerwin (2000):Pharmacogenetic prediction of Clozapine response;
Lancet 355: 1616-1616. (Impact Factor 2004: 21.713).
 

25. G. Stöber, J. Meyer, I. Nanda, T. F. Wienker, K. Saar, S. Jatzke, M. Schmid, K.-P. Lesch, H. Beckmann (2000):
hKCNN3, which maps to chromosome 1q21, is not the causative gene in periodic catatonia, a familial subtype of schizophrenia;
Eur. Arch. Psychiatr. Clin. Neurosci. 250: 163-168. (Impact Factor 2004: 1.520).
              

24. G. Stöber, J. Meyer, I. Nanda, T. F. Wienker, K. Saar, M. Knapp, S. Jatzke, M. Schmid, K. P. Lesch,    H. Beckmann (2000):
Linkage and family-based association study of schizophrenia and the synapsin III locus which maps to chromosome 22q13;
Am. J. Med. Genet. 96: 392-397. (Impact Factor 2005: 3.521)
.

23. G. Stöber, K. Saar, F. Rüschendorf, J. Meyer, G. Nürnberg, E. Franzek, A. Reis, K. P. Lesch, T. F. Wienker, H. Beckmann (2001):
Splitting schizophrenia: Periodic catatonia susceptibility locus on chromosome 15q15;
Am. J. Hum. Genet. 67: 1201-1207. (Impact Factor 2001: 10.542).
 

22. J. Deckert, J. Meyer, M. Catalano, M. Bosi, P. Sand, D. DiBella, G. Ortega, G. Stöber,P. Franke, M. M. Nöthen, J. Fritze,
W. Maier , H. Beckmann, P. Propping, L. Bellodi, K. P. Lesch (2000):
Novel 5'-regulatory region polymorphisms of the 5HT2C receptor gene: Association study with panic disorder;
Int. J. Neuropsychopharmacology 3: 321-325. (Impact Factor 2005: 3.918).
              

21. Y. V. Syagailo, G. Stöber, M. Gräßle, E. Reimer, M. Knapp, O. Okladnova, J. Meyer, K. P. Lesch (2001):
Association analysis of the functional monoamine oxidase A gene promoter polymorphism in psychiatric disorders;
Am. J. Med. Genet. 105: 168-171. (Impact Factor 2005: 3.521).
             

20. C. Rubie, F. Schmidt, M. Knapp, J. Sprandel, C. Wiegand, J. Meyer, G. Jungkunz, P. Riederer, G. Stöber (2001):
The human dopamine transporter gene: the 5'-flanking region reveals five diallelic polymorphic sites in a Caucasian population sample;
Neurosci. Lett. 297: 125-128. (Impact Factor 2005: 1.898).
 

19. J. Meyer, A. Huberth, G. Ortega, Y. V. Syagailo, S. Jatzke, R. Mössner, I. Ulzheimer-Teuber, T. M. Strom, G. Stöber, A. Schmitt, K. P. Lesch (2001):
A missense mutation in a novel gene encoding a putative cation channel is associated with catatonic schizophrenia in a large pedigree;
Mol. Psychiatry 6: 302-306. ## (Impact Factor 2005: 9.335).
 

18. J. Gross, O. Grimm, G. Ortega, I. Teuber, K. P. Lesch, J. Meyer (2001):
Mutational analysis of the neuronal cadherin gene CELSR1 and exclusion as a candidate for catatonic schizophrenia in a large family;
Psychiatr. Genet. 11: 197-200. (Impact Factor 2005: 2.366).
 

17. J. Meyer, G. Ortega, K. Schraut, G. Nürnberg, F. Rüschendorf, K. Saar, R. Mössner, T. F. Wienker, A. Reis,
G. Stöber, K. P. Lesch (2002):
Exclusion of the neuronal nicotinic acetylcholine receptor a7 subunit gene as a candidate for catatonic schizophrenia in alarge family
supporting the 15q13-22 locus;
Mol. Psychiatry 7: 220-223. (Impact Factor 2005: 9.335).
 

16. J. M. Devaney, E. Donarum, K. M. Brown, J. Meyer, G. Stöber, K. P. Lesch, D. A. Stephan, A. E. Pulver (2002):
No missense mutation of WKL1 in a subgroup of probands with schizophrenia;
Mol. Psychiatry 7: 419-423. (Impact Factor 2005: 9.335).
 

15. Y. V. Syagailo, O. Okladnova, E. Reimer, M. Grässle, R. Mössner, S. Gattenlöhner, A. Marx, J. Meyer, K. P. Lesch (2002):
Structural and functional characterization of the PAX7 5‘-flanking regulatory region;
Gene 294: 259-268. (Impact Factor 2005: 2.694).
 

14. J. Meyer, M. Mai, G. Ortega, R. Mössner, K. P. Lesch (2002):
Mutational analysis of the connexin 36 gene (CX36) and exclusion of the coding sequence as a candidate region for catatonic
schizophrenia in a large pedigree;
Schizophr. Res. 58: 87-91. (Impact Factor 2005: 4.231).
 

13. J. Meyer, W. Saam, R. Mössner, G. Ortega, T. Tatschner, P. Riederer, K. P. Lesch (2002): Evolutionary conserved
microsatellites in the promoter region of the 5-hydroxytryptamine receptor 2C gene (HTR2C) are not associated with bipolar disorder in females;
J. Neural Transm. 109: 939-946. (Impact Factor 2004: 2.628).

 

1992 – 1999

12. K. P. Lesch, J. Meyer, K. Glatz, G. Flügge, A. Hinnney, J. Hebebrand, S. M. Klauck, A. Poustka, F. Poustka, D. Bengel, R. Mössner,
P. Riederer, A. Heils (1997):
The 5-HT transporter gene-linked polymorphic region (5-HTTLPR) in evolutionary perspective: alternative biallelic variation in rhesus monkeys;
J. Neural Transm. 104: 1259-1266.
 

11. J. Meyer, P. Wiedemann, O. Okladnova, M. Brüss, T. Staab, G. Stöber, P. Riederer, H. Bönisch, K. P. Lesch (1998): Cloning and functional characterization of the human norepinephrine transporter gene promoter;
J. Neural Transm. 105: 1341-1350.


10. G. Stöber, S. Jatzke, J. Meyer, O. Okladnova, M. Knapp, H. Beckmann, K. P. Lesch (1998):
Short CAG repeats within the hSKCa3 gene associated with schizophrenia:
Results of a family-based study;
NeuroReport 9: 3595-3599.


9. K. P. Lesch, S. Jatzke, J. Meyer, G. Stöber, O. Okladnova, R. Mössner, P. Riederer (1999):
Mosaicism for a serotonin transporter gene promoter-associated deletion:decreased recombination in depression;
J. Neural Transm. 106: 1223-1230.


8. J. Meyer, P. Südbeck, M. Held, T. Wagner, M. L. Schmitz, F. Dagna Bricarelli, E. Eggermont, U. Friedrich, O. A. Haas,
A. Kobelt, J. G. Leroy, L. Van Maldergem, E. Michel, B. Mitulla, R. A. Pfeiffer, A. Schinzel, H. Schmidt, G. Scherer (1997):
Mutational analysis of the SOX9 gene in both campomelic dysplasia and autosomal sex reversal: lack of genotype/phenotype correlations;
Hum. Mol. Genet. 6: 91-98. (Impact Factor 1997: 8.505).
 

7.J. Wirth, T. Wagner, J. Meyer, R. A. Pfeiffer, H.-U. Tietze, W. Schempp, G. Scherer (1996): Translocation breakpoints in
three patients with campomelic dysplasia and autosomal sex reversal map over 130 kb from SOX9;
Hum. Genet. 97: 186-193.
 

6. J. Meyer, J. Wirth, M. Held, W. Schempp, G. Scherer (1996):
SOX20, a new member of the SOX gene family, is located on chromosome 17p13;
Cytogenet. Cell Genet. 72: 246-249; OMIM *601297.
 

5. T. Wagner, J. Wirth, J. Meyer, B. Zabel, M. Held, J. Zimmer, J. Pasantes, F. Dagna Bricarelli, J. Keutel, E. Hustert, U. Wolf,
N. Tommerup, W. Schempp, G. Scherer (1994): Autosomal sex reversal and campomelic dysplasia are caused by mutations
in and around the SRY-related Gene SOX9;
Cell 79: 1111-1120. (Impact Factor 1994: 39.191).
 

4. J. Meyer, S. Nick, T. Stamminger, F. Grummt, G. Jahn, H. J. Lipps (1993):
Inhibition of HIV-1 replication by a high-copy-number vector expressing antisense RNA for reverse transcriptase; Gene 129: 263-268. #.
 

3. S. Weber, M. Schmid, J. Meyer, H. J. Cooke, H. J. Lipps (1993):
A linear vector carrying human telomeres is replicated in unfertilized eggs of Xenopus laevis;
Cell Biol. Int. 17: 623-624.
 

2. C. Eder, C. Maercker, J. Meyer, H. J. Lipps (1993):
The processing of macronuclear DNA sequences during macronuclear development of the hypotrichous ciliate Stylonychia lemnae;
Int. J. Dev. Biol. 37: 473-477.
 

1. H. Hameister, W. A. Schulz, J. Meyer, S. Thoma, S. Adolph, A. Gaa, O. von Deimling (1992):
Gene order and genetic distance of 13 loci spanning murine chromosome 15;
Genomics 14: 417-422.

 

REVIEW

J. Gross, J. Meyer, K. P. Lesch (2003):The Cadherin Hypothesis of Schizophrenia;Fortschr. Neurol. Psychiatr. 71: 84-88. Review. [German].

 

SCIENTIFIC CORRESPONDENCE

C. M. Freitag, J. Meyer, A. Reif., M. Rösler, K. P. Lesch, W. Retz (2008):
Environmental risk factors and Attention Deficit/Hyperactivity Disorder symptoms;
Arch. Gen. Psychiatry 65: 356 - 357. (Impact Factor 2005: 12.642).

R. Mössner, C. M. Freitag, M. Marziniak, D. Moser, C. Sommer, J. Meyer (2006):
The functional Val158Met variant of the COMT gene is not associated with migraine with or without aura;           J. Headache Pain 7: 165-166. (Impact Factor 2005: 2.455).

J. Meyer, F. Rüschendorf, K.p: Lesch (2003):
A second large family with catatonic schizophrenia supports the region distally of
CHRNA7 on chromosome 15q14-15; Mol. Psychiatry 8: 259-260.
(Impact Factor 2005: 9.335).

J. Meyer, S. Scherer, R. Mössner, K. P. Lesch (2002):
KIAA0027 (WKL1, MLC1) and psychosis: White matters;
Mol. Psychiatry 7: 1037-1038. (Impact Factor 2005: 9.335).

 

REVIEWS, COMMENTS AND EDITORIALS CONCERNING JOBST MEYER'S WORK 

Y. Kohn (2005):
Focus on Rare genetic variants in bipolar disorder: how outliers help understand complex disorders.
Int. J. Neuropsychopharmacol. 8: 491-493.

M. L. Wong (2001):
The C/At is out of the bag: a gene for mental illness.
Pharmacogenomics J 1: 13-14.

K. Mirnics K, D. A. Lewis (2001):
Genes and subtypes of schizophrenia.
Trends Mol. Med. 7: 281-283.

 

AWARDS

Award (1995) of the German Society of Human Genetics together with Thomas Wagner and Jutta Wirth for positional cloning of the SOX9 gene as the cause for Campomelic Dysplasia with congenital XY sex reversal;
Cell 79: 1111-1120 (1995).

Best overall conference paper award (2012): „Can genotype predict player type?“
2012 NeuroPsychoEconomics Conference, Rotterdam School of Management, Erasmus University;
PLOS ONE 6(6): e20959. (Epub 2011 Jun 16).